Esperion Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $11k | 3.8k | 2.99 |
| 2023-09-30 | $3.7k | 3.8k | 0.98 |
| 2023-06-30 | $9.9k | 7.1k | 1.39 |
| 2023-03-31 | $158k | 100k | 1.59 |
| 2022-12-31 | $578k | 93k | 6.23 |
| 2022-09-30 | $574k | 86k | 6.70 |
| 2022-06-30 | $482k | 76k | 6.37 |
| 2022-03-31 | $249k | 54k | 4.64 |
| 2021-12-31 | $156k | 31k | 5.01 |
| 2021-09-30 | $381k | 32k | 12.05 |
| 2021-06-30 | $695k | 33k | 21.14 |
| 2021-03-31 | $900k | 32k | 28.06 |
| 2020-12-31 | $909k | 35k | 26.01 |
| 2020-09-30 | $1.3M | 34k | 37.18 |
| 2020-06-30 | $2.2M | 44k | 51.32 |
| 2020-03-31 | $1.2M | 38k | 31.54 |
| 2019-12-31 | $2.3M | 39k | 59.64 |
| 2019-09-30 | $1.3M | 36k | 36.66 |
| 2019-06-30 | $1.7M | 36k | 46.51 |
| 2019-03-31 | $1.3M | 31k | 40.16 |
| 2018-12-31 | $1.5M | 32k | 46.01 |
| 2018-09-30 | $965k | 22k | 44.37 |
| 2018-06-30 | $904k | 23k | 39.20 |
| 2018-03-31 | $1.2M | 17k | 72.35 |
| 2017-12-31 | $1.2M | 18k | 65.85 |
| 2017-09-30 | $1.0M | 21k | 50.10 |
| 2017-06-30 | $858k | 19k | 46.28 |
| 2017-03-31 | $677k | 19k | 35.30 |
| 2016-12-31 | $205k | 16k | 12.55 |
| 2016-09-30 | $240k | 17k | 13.84 |
| 2016-06-30 | $170k | 17k | 9.89 |
| 2016-03-31 | $229k | 14k | 16.93 |
| 2015-12-31 | $299k | 13k | 22.23 |
| 2015-09-30 | $285k | 12k | 23.60 |
| 2015-06-30 | $939k | 12k | 81.76 |
| 2015-03-31 | $490k | 5.3k | 92.63 |